B. C. scientists have been able to develop an untried new drug that is capable of shrinking prostate cancer tumors, which is based on molecules taken out from a marine sponge collected in New Guinea.
Their reading, published on Monday in the journal Cancer Cell, depicts the experimental drug, EPI-001, not only helped shrink tumors but did so with no obvious toxic effects on the cancer-afflicted laboratory mice, who received injections of the drug.
Marianne Sadar, a Scientist with the BC Cancer Agency said that the day she saw tumors were actually shrinking and she hurriedly ran all around the building trying to show everyone the pictures of shrunk tumors.
Sadar has put in a number of years searching for new drugs that help men suffering from relapses when their cancer becomes defiant to what’s named as androgen ablation therapy: surgical or drug treatment that is meant to prevent production of male hormones, testosterone, that work as fuel towards the growth of tumor.
In such men, prostate cancer starts growing and average therapies might augment survival only for about two months time, as per the new study.
No comments:
Post a Comment